Advertisement

Topics

Companies Related to "The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215" [Most Relevant Company Matches] RSS

22:00 EST 21st February 2019 | BioPortfolio

Here are the most relevant search results for "The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215" found in our extensive corporate database of over 50,000 company records.

Showing "Neuropsychiatric Evaluation Positive Negative Drug Using Individuals Study" Companies 1–25 of 5,500+

Relevant

Neuropsychiatric Research Institute

The mission of the Neuropsychiatric Research Institute is to improve the health status of individuals. This will be done by establishing and maintaining affiliations with core partners to create a center of excellence in the neurosciences that will enhance clinical expertise through education, research, and service.The Neuropsychiatric Research Institute was created to be a catalyst for supporting...


Pharmakin GmbH

Founded in 1987, Pharmakin has since then successfully provided competent bioanalysis and pharmacokinetic evaluation of new chemical entities, marketed drugs and their metabolites. Analysis is performed in GLP-certified laboratories by our highly qualified expert staff. State-of-the-art bioanalytical techniques are applied to all analytical procedures. Pharmakin’s services also include pharmacok...

Microbiotix, Inc.

Microbiotix, Inc. is a privately held, product-focused biopharmaceutical company engaged in the research and development of novel small molecule, anti-infective drugs that address commercially significant medical markets. The company currently has four novel compound series in research and development. Microbiotix currently has in development MBX 500, the first antibiotic that targets the DNA po...


Privia

A clinical trial is a research study. Research studies are used to decide how treatments work and how safe they are. While in a study, a person may receive either an investigational drug, a marketed drug, a placebo, or a combination of these. An investigational drug is one that is nor approved by the Food and Drug Administration, a marketed drug is FDA approved and a placebo is like a "sugar pill"...

MicuRx Pharmaceuticals, Inc.

MicuRx is discovering and developing novel antibiotics to combat infections due to resistant bacteria. Positioned to capture the benefits of United States research and development expertise together with China's abundant scientific talent and cost-effective discovery, preclinical and development, the company has built a pipeline of drug candidates for the treatment of gram positive, gram negative ...

American Asian Bio-Pharma Services, Inc

AA Bio-Pharma is a Clinical Research Organization (CRO) with US headquarters. It specializes in serving pharmaceutical, biotechnology, and medical device companies worldwide for pre-clinical and clinical studies in Asia, China. In the past years, AA Bio-Pharma with its partners in China has provided drug development services for sponsors around the world.Our services include:Pre-clinical Researc...

Achaogen, Inc.

Achaogen is a clinical-stage biopharmaceutical company focused on the discovery and development of antibiotics for the treatment of serious infections caused by multi-drug resistant, Gram-negative bacteria. The company’s pipeline includes ACHN-490, an aminoglycoside currently being evaluated in a Phase 2 clinical study for the treatment of complicated ...

Bioharmony Therapeutics, Inc.

Bioharmony Therapeutics, Inc. is an emerging biopharmaceutical company focused on the discovery and development of first-in-class lysin-based antimicrobial therapeutics for patients with multi-drug resistant Gram-negative bacterial infections. In addition to the Acinetobacter lysin, Bioharmony’s portfolio includes a proprietary line-up of lysins for t...

Macrolide Pharmaceuticals

Macrolide Pharmaceuticals focuses on the discovery and development of novel macrolide antibiotics for the treatment of life-threatening bacterial infections caused by drug resistant pathogens. Using novel technology, Macrolide Pharmaceuticals can synthesize a broad range of macrolides, and initial compounds show promising anti-bacterial activity. The compa...

Trius Therapeutics, Inc.

Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for serious, life-threatening infections. The company's first product candidate, torezolid phosphate, is an IV and orally administered second generation oxazolidinone being developed for the treatment of serious gram-positive infections, including those caused by ...

Corcept Therapeutics

Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the development of drugs for the treatment of severe psychiatric and neurological diseases. Our lead product, CORLUX, is currently in three Phase 3 clinical trials for the treatment of the psychotic features of psychotic major depression (PMD), a disorder that affects approximately three million adults in the United States ea...

Assurex Health

Assurex Health is a personalized medicine company that specializes in pharmacogenomics and is dedicated to helping physicians determine the right medication for individual patients with neuropsychiatric and other medical conditions. The company was founded to commercialize industry-leading personalized medicine technology for neuropsychiatric conditions. A...

The Drug & Device Development Co., Inc

The Drug & Device Development Co., Inc. founded in 1985, has expertise in the regulatory, clinical, quality and statistical aspects of drug, biologic, diagnostic, and medical device development. The DDD group consists of both full-time and part-time specialists. Each one is well experienced in one or more aspects of the drug, biologic and/or device approval process.The major focus of DDD's service...

KARD Scientific

KARD scientific is the reliable resource for all your in vivo efficacy studies in drug discovery and development. For high quality, efficiency and cost effective services in cancer, neurological, inflammation, arthritis and other disease models. We can assist you in study design and methods for screening. We optimize the schedule, time points, routes, and combination studies, while keeping cl...

vTv Therapeutics Inc. vTv Therapeutics Inc. vTv Therapeutics Inc.

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv has a pipeline of clinical drug candidates led by programs for the treatment of Alzheimer’s disease and diabetes as well as treatment of inflamma...

Psylin Neurosciences, Inc.

Psylin Neurosciences, Inc. was formed in January, 2007 as a 50/50 joint venture biotechnology company spun out of Amylin Pharmaceuticals, Inc. and PsychoGenics, Inc. Psylin's mission is to pioneer the development of peptide therapeutics in neuropsychiatric disorders. Psylin has access to molecules in Amylin's PHORMOL library and to PsychoGenics' proprietary drug discovery technologies. Amylin's e...

Assessment Consultants, Inc

Assessment Consultants, Inc. helps individuals, employers, and organizations respond effectively to the complex challenges of the modern work world. We believe the application of psychological science to the understanding of personality, intellectual capacity, cognitive aptitudes, interpersonal style, and vocational interest provides the conditions for effectively making personal career choices, o...

Auspherix Limited

Auspherix Ltd has discovered a brand new class of antibacterials with a unique profile and novel mechanism of action that could overcome rising problems of resistance to current antibiotics. Its compound series show activity against a broad range of multidrug resistant (MDR) important Gram-negative and Gram-positive bacterial, with PK profiles consistent w...

Auspherix Limited (UK)

Auspherix Ltd has discovered a brand new class of antibacterials with a unique profile and novel mechanism of action that could overcome rising problems of resistance to current antibiotics. Its compound series show activity against a broad range of multidrug resistant (MDR) important Gram-negative and Gram-positive bacterial infections, with profiles cons...

APSciences, Inc.

Dr. Albert P. Li has over 30 years of experience in drug discovery and development. He was one of the pioneers in the application of in vitro systems in the evaluation of drug properties. He co-developed the CHO/HGPRT gene mutation system for industrial applications early in his career in Oak Ridge National Laboratory, Lovelace Inhalation Toxicology Research Institute and Monsanto Company. He was ...

OncoRx Pharmaceuticals Inc.

OncoRx Pharmaceuticals (www.oncorxpharmaceuticals.com) is an early-stage pharmaceutical company dedicated to the discovery and development of novel drugs that control tumor metastasis; disrupt proliferation; and downregulate tissue invasion of drug-resistant tumor cells. In the near term, the Company is planning clinical development programs for the treatm...

PharmaLinkFHI, Inc.

PharmaLink provides complete eClinical research services to support and streamline the drug development process. Clinical teams leverage real-time study information to make immediate decisions based on emerging trends and study issues. Our accelerated processes, centralized information management and global reach make it possible to conduct trials of any size or complexity from virtually anywhere....

Apredica

Apredica provides contract research services for the evaluation and optimization of the Absorption, Distribution, Metabolism, Elimination, Toxicity - (ADMET) - and Pharmacokinetic properties of drug candidates early in the drug-discovery process.

BioClin Therapeutics, Inc.

BioClin Therapeutics, Inc. is a privately-held clinical stage drug development company developing biologics to address medical conditions in areas of high unmet need. The company’s lead candidate is B-701, a potential first-in-class human monoclonal antibody targeting FGFR3 (fibroblast growth factor receptor 3). B-701 is currently being evaluated in t...

Mpex Pharmaceuticals, Inc.

Mpex Pharmaceuticals is a clinical stage biopharmaceutical company whose mission is to develop important new therapies to combat the growing issue of antibiotic resistance. The company's internal development pipeline focuses on combining proprietary formulations, PK/PD strategies and novel potentiating agents with proven antibiotics to overcome or directly inhibit the molecular mechanisms in bacte...


More From BioPortfolio on "The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks